Breast cancer’s intrinsic subtypes, identified by the expression of the proliferation marker Ki-67, human epidermal growth factor receptor 2 (HER2), progesterone receptor (PR), and estrogen receptor (ER), reveal the intricacy of the disease [87] (Figure 3). This evidence concerns the gene ERBB2 and breast carcinoma.